Endoglin

Endoglin信息

英文名称:Endoglin上市药物数量0
中文名称内皮因子临床药物数量3
靶点别称CD105 Antigen,CD105,END,ENG,Osler-Rendu-Weber Syndrome 1,HHT1,ORW1,Endoglin最高研发阶段临床二期
英文名称:Endoglin
中文名称内皮因子
靶点别称CD105 Antigen,CD105,END,ENG,Osler-Rendu-Weber Syndrome 1,HHT1,ORW1,Endoglin
上市药物数量0
临床药物数量3
最高研发阶段Phase 2 Clinical

Endoglin产品列表

  • 属性

    Protein (1)

  • 产品库

    在线 (1)

  • 物种

    Human (1)

  • 标签

    His Tag (1)

  • 标记

    Unconjugated (1)

共 1 项数据
  • 1

Endoglin分子背景

Endoglin (ENG), endothelial glycoprotein, also known as CD105, is a coreceptor of the transforming growth factor-β (TGFβ) family signaling complex, which is highly expressed on endothelial cells and plays a key role in angiogenesis. It regulates the responses associated with binding to transforming growth factor β1 egg (Activin-A), bone morphogenetic protein 2 (BMP-2), and bone morphogenetic protein 7 (BMP-7). Endoglin may be involved in autosomal dominant disease, such as hereditary hemorrhagic telangiectasia 1 (HHT1). Circulating soluble ENG is also elevated in pulmonary arterial hypertension(PAH) and is proposed to be a biomarker for the prognosis of group I PAH patients.

Endoglin分子别名

Endoglin,CD105,ENG,END
  • 分子信息
  • 产品列表